Recent Press Releases

Catalent Adds Global Particle Size Technology Leader To Industry's Broadest Bioavailability And Delivery Technology Offerings

Somerset, N.J. – November 13, 2014 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

WuXi PharmaTech Announces Third-Quarter 2014 Results

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities At Kansas City Campus

Somerset, N.J. — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today...

inVentiv Health Names Jeffrey Wilks as President of Advertising

NEW YORK -- inVentiv Health, Inc. ("inVentiv"), a life science knowledge and services company for the new healthcare environment, today announced the appointment of Jeffrey Wilks as...

GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience

HYDERABAD, India--Asia's leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical...

ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials

DUBLIN--ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a...

Charles River's Early Drug Discovery Business and CHDI Foundation Extend Huntington's Disease Collaboration

WILMINGTON, Mass.--Charles River Laboratories International, Inc. announced today that CHDI Foundation, Inc. has extended its ongoing collaboration for an additional five years through 2019. The...

Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring

NEW YORK--Medidata (NASDAQ:MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract...

AMRI Announces Third Quarter 2014 Results

- Third quarter contract revenue of $57.5 million, up 8% from 2013 - Lower Discovery and API revenue is offset by addition of OsoBio - OsoBio business interruption contributes to third quarter...

Chiltern is Designed Around You

LONDON and WILMINGTON, N.C., Nov. 3, 2014 -- With a renewed therapeutic specialization, deepened service offering and expanded geographic footprint, Chiltern launches today as a completely integrated...

WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

Paragon Bioservices Raises $13 Million in Financing, Led by NewSpring Capital and Camden Partners

BALTIMORE, Oct. 28, 2014 /PRNewswire/ -- Paragon Bioservices, Inc. ("Paragon"), a privately held contract research and manufacturing organization whose mission is to accelerate the...

LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World's Leading Healthcare Diagnostics Company

Covance shareholders to receive cash and LabCorp shares currently valued at $105.12 per Covance share Combination creates comprehensive healthcare diagnostics company offering customers end-to-end...

Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing Operations

– Third-Quarter Revenue of $327.6 Million – – Third-Quarter GAAP Earnings per Share of $0.68 and Non-GAAP Earnings per Share of $0.86 – – Updates EPS Guidance for 2014...

Quintiles Reports 3rd Quarter 2014 Results

13.8% consolidated service revenue growth - Integrated Healthcare Services segment grew service revenues by 32.6% compared to the third quarter of 2013 Consolidated book-to-bill ratio of 1.42...

SRI International Opens Clinical Trial Unit in Michigan Life Science Innovation Center

MENLO PARK, Calif. -- SRI Biosciences, a division of SRI International, has completed construction of an early-phase clinical trial facility in Plymouth, Michigan. The 9,400-square foot unit, located...

Veeva Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform

Clients benefit from complete access, visibility, and control throughout the clinical trial inVentiv Health Clinical, a leading global supplier of drug development services, will replace its...

Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China

Ge Li, chairman and chief executive officer of WuXi. "WuXi has seen rapidly increasing demand for molecular profiling services from biopharmaceutical companies as they scale up R&D...

Charles River Laboratories Introduces PTS-Micro™ System for Rapid Microbial Burden Testing

WILMINGTON, Mass.—October 20, 2014 – Charles River Laboratories International, Inc. (NYSE: CRL) today introduced the PTS-Micro™ system, a new technology platform designed for rapid...

DKSH extends relationship with Roche across Asia

DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Roche to extend the duration of its decades-long partnership across Asian markets and expand...